13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 26 holding rows worth $684,730,000.
- Accession
- 0001144204-17-008904
- Filer
- CIK 1346824
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 26 entries on the cover page, a total value of $684,730,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $684,730,000 with VALUE read as thousands by filing date, 13F file number 028-12884. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,088,651 | $185,368,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 5,409,990 | $109,498,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 1,890,796 | $90,248,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 13,633,220 | $56,305,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 2,191,977 | $36,190,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 2,451,237 | $29,783,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 1,935,305 | $27,481,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 1,820,138 | $20,204,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,989,795 | $18,925,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 1,190,270 | $18,080,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 692,563 | $14,634,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 677,663 | $13,858,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 532,426 | $9,727,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 240,000 | $7,286,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $6,994,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 1,142,857 | $5,543,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 2,279,099 | $5,470,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,004,314 | $4,670,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 2,389,700 | $4,660,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 591,070 | $4,179,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 354,200 | $4,126,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 928,199 | $4,038,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 2,250,000 | $3,375,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 79,899 | $2,712,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 101,439 | $714,000 | thousands by filing date | |
| ARCA BIOPHARMA INC | 00211Y407 | COM PAR | 232,245 | $662,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-17-008904 | this filing | 2017-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001144204-17-009568 | base | 2017-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001144204-17-009569 | added | 2017-02-16 | acceptance time not in the bulk data set |